Christopher Ma, Michelle Downes, Rahi Jain, Marc Ientilucci, Neil Fleshner, Nathan Perlis, Theodorus van der Kwast
{"title":"伴有同步或异时转移性疾病的2级组前列腺切除术标本中不良病理特征的患病率","authors":"Christopher Ma, Michelle Downes, Rahi Jain, Marc Ientilucci, Neil Fleshner, Nathan Perlis, Theodorus van der Kwast","doi":"10.1002/pros.24279","DOIUrl":null,"url":null,"abstract":"To validate the importance of recently established adverse histopathology features (cribriform pattern and intraductal carcinoma) as contra‐indication for deferred treatment of Gleason score 7 (3 + 4) (grade group [GG] 2) prostate cancer, we investigated their frequency in GG2 radical prostatectomies with syn‐ or metachronous metastatic disease.","PeriodicalId":501684,"journal":{"name":"The Prostate","volume":" ","pages":"345-351"},"PeriodicalIF":0.0000,"publicationDate":"2022-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"3","resultStr":"{\"title\":\"Prevalence of adverse pathology features in grade group 2 prostatectomy specimens with syn- or metachronous metastatic disease.\",\"authors\":\"Christopher Ma, Michelle Downes, Rahi Jain, Marc Ientilucci, Neil Fleshner, Nathan Perlis, Theodorus van der Kwast\",\"doi\":\"10.1002/pros.24279\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"To validate the importance of recently established adverse histopathology features (cribriform pattern and intraductal carcinoma) as contra‐indication for deferred treatment of Gleason score 7 (3 + 4) (grade group [GG] 2) prostate cancer, we investigated their frequency in GG2 radical prostatectomies with syn‐ or metachronous metastatic disease.\",\"PeriodicalId\":501684,\"journal\":{\"name\":\"The Prostate\",\"volume\":\" \",\"pages\":\"345-351\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-02-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"3\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"The Prostate\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1002/pros.24279\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2021/12/8 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Prostate","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1002/pros.24279","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2021/12/8 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
Prevalence of adverse pathology features in grade group 2 prostatectomy specimens with syn- or metachronous metastatic disease.
To validate the importance of recently established adverse histopathology features (cribriform pattern and intraductal carcinoma) as contra‐indication for deferred treatment of Gleason score 7 (3 + 4) (grade group [GG] 2) prostate cancer, we investigated their frequency in GG2 radical prostatectomies with syn‐ or metachronous metastatic disease.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
